These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27649963)

  • 1. Surface display on lactic acid bacteria without genetic modification: strategies and applications.
    Mao R; Wu D; Wang Y
    Appl Microbiol Biotechnol; 2016 Nov; 100(22):9407-9421. PubMed ID: 27649963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterologous surface display on lactic acid bacteria: non-GMO alternative?
    Zadravec P; Štrukelj B; Berlec A
    Bioengineered; 2015; 6(3):179-83. PubMed ID: 25880164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal vaccination and therapy with genetically modified lactic acid bacteria.
    Wells J
    Annu Rev Food Sci Technol; 2011; 2():423-45. PubMed ID: 22129390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Display of recombinant proteins at the surface of lactic acid bacteria: strategies and applications.
    Michon C; Langella P; Eijsink VG; Mathiesen G; Chatel JM
    Microb Cell Fact; 2016 May; 15():70. PubMed ID: 27142045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretory expression and surface display of a new and biologically active single-chain insulin (SCI-59) analog by lactic acid bacteria.
    Mao R; Wu D; Hu S; Zhou K; Wang M; Wang Y
    Appl Microbiol Biotechnol; 2017 Apr; 101(8):3259-3271. PubMed ID: 28120013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autotransporter-based cell surface display in Gram-negative bacteria.
    Nicolay T; Vanderleyden J; Spaepen S
    Crit Rev Microbiol; 2015 Feb; 41(1):109-23. PubMed ID: 23855358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune modulatory capacity of probiotic lactic acid bacteria and applications in vaccine development.
    Mojgani N; Shahali Y; Dadar M
    Benef Microbes; 2020 May; 11(3):213-226. PubMed ID: 32216470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current issues regarding the application of recombinant lactic acid bacteria to mucosal vaccine carriers.
    Takahashi K; Orito N; Tokunoh N; Inoue N
    Appl Microbiol Biotechnol; 2019 Aug; 103(15):5947-5955. PubMed ID: 31175431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic expression of a model antigen with M Cell-Targeting moiety in lactic acid bacteria and implication of the mechanism as a mucosal vaccine via oral route.
    Oh SH; Kim SH; Jeon JH; Kim EB; Lee NK; Beck S; Choi YJ; Kang SK
    Vaccine; 2021 Jul; 39(30):4072-4081. PubMed ID: 34127296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against human papillomavirus type 16-induced tumors in mice using non-genetically modified lactic acid bacteria displaying E7 antigen at its surface.
    Ribelles P; Benbouziane B; Langella P; Suárez JE; Bermúdez-Humarán LG
    Appl Microbiol Biotechnol; 2013 Feb; 97(3):1231-9. PubMed ID: 23212671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anchoring of proteins to lactic acid bacteria.
    Leenhouts K; Buist G; Kok J
    Antonie Van Leeuwenhoek; 1999; 76(1-4):367-76. PubMed ID: 10532392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactic acid bacteria as a surface display platform for Campylobacter jejuni antigens.
    Kobierecka P; Wyszyńska A; Maruszewska M; Wojtania A; Żylińska J; Bardowski J; Jagusztyn-Krynicka EK
    J Mol Microbiol Biotechnol; 2015; 25(1):1-10. PubMed ID: 25662187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel bacterium-like particles platform displaying antigens by new anchoring proteins induces efficacious immune responses.
    Niu L; Gao M; Ren H; De X; Jiang Z; Zhou X; Liu R; Li H; Duan H; Zhang C; Wang F; Ge J
    Front Microbiol; 2024; 15():1395837. PubMed ID: 38841059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in engineering acid stress resistance of lactic acid bacteria.
    Wu C; Huang J; Zhou R
    Appl Microbiol Biotechnol; 2014 Feb; 98(3):1055-63. PubMed ID: 24337395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant lactic acid bacteria as mucosal biotherapeutic agents.
    Daniel C; Roussel Y; Kleerebezem M; Pot B
    Trends Biotechnol; 2011 Oct; 29(10):499-508. PubMed ID: 21665301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards a nanoscale view of lactic acid bacteria.
    Tripathi P; Beaussart A; Andre G; Rolain T; Lebeer S; Vanderleyden J; Hols P; Dufrêne YF
    Micron; 2012 Dec; 43(12):1323-30. PubMed ID: 22293169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different impact of heat-inactivated and viable lactic acid bacteria of aquatic origin on turbot (Scophthalmus maximus L.) head-kidney leucocytes.
    Muñoz-Atienza E; Araújo C; Lluch N; Hernández PE; Herranz C; Cintas LM; Magadán S
    Fish Shellfish Immunol; 2015 May; 44(1):214-23. PubMed ID: 25707601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotechnological applications for surface-engineered bacteria.
    Wernérus H; Ståhl S
    Biotechnol Appl Biochem; 2004 Dec; 40(Pt 3):209-28. PubMed ID: 15035661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell surface engineering of microorganisms towards adsorption of heavy metals.
    Li PS; Tao HC
    Crit Rev Microbiol; 2015 Jun; 41(2):140-9. PubMed ID: 23915280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An efficient bacterial surface display system based on a novel outer membrane anchoring element from the Escherichia coli protein YiaT.
    Han MJ; Lee SH
    FEMS Microbiol Lett; 2015 Jan; 362(1):1-7. PubMed ID: 25790485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.